Home › Research › Clinical trials
Clinical trials
Every Alzheimer's trial in our copy of the ClinicalTrials.gov registry — completed, running and abandoned. Filter it, then follow the link to the official record.
If you are thinking about joining a trial
A listing here is a record that a study was registered. It is not a recommendation, and it does not mean the study is still recruiting or that anyone is eligible. Registry entries go stale.
Talk to the treating doctor first, then contact the study team listed on the official ClinicalTrials.gov record. The NIA's free referral line can help you look: 1-800-438-4380, weekdays, English and Spanish.
Showing 5,976–6,000 of 7,816 matching trials · page 240 of 313, 25 per page.
Sorted by the date the registry record was last updated, newest first. This page never loads all 7,816 rows at once — use the CSV download if you want the whole file.
| Trial | Phase | Status | Enrolled | Sponsor | Last updated |
|---|---|---|---|---|---|
|
Impact of Emotional Mimicry and Oxytocin on Frontotemporal Dementia NCT01937013 Intranasal oxytocin; Saline Nasal Mist Runs in: Canada · 1 site |
PHASE2 other |
COMPLETED | 52 | London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's OTHER |
2018-08-08 |
|
Study of tDCS for Mild Cognitive Impairment NCT02320890 YBand (YDT-201N); sham-YBand (YDT-201N) Runs in: South Korea · 1 site |
NA other |
COMPLETED | 16 | Incheon St.Mary's Hospital OTHER |
2018-08-08 |
|
18F-S16 PET/CT in Healthy Volunteers and Patients With Neurodegenerative Dementia NCT03620552 18F-S16 Runs in: China · 1 site |
EARLY_PHASE1 other |
UNKNOWN | 30 | Oriental Neurosurgery Evidence-Based-Study Team OTHER |
2018-08-08 |
|
Optimal Dose Escalation Strategy to Successful Achievement of High Dose Donepezil 23mg NCT02550665 donepezil Runs in: South Korea · 1 site |
PHASE3 symptomatic-cholinergic |
COMPLETED | 176 | Asan Medical Center OTHER |
2018-08-07 |
|
A Clinical Study to Evaluate the Pharmacokinetics (PK) of Corplex™ Donepezil Transdermal Delivery System (TDS) Applied to Different Body Locations NCT03432195 Donepezil TDS Runs in: United States · 1 site |
PHASE1 symptomatic-cholinergic |
COMPLETED | 66 | Corium, Inc. INDUSTRY |
2018-08-07 |
|
Dementia-specific Intervention of Advance Care Planning NCT03615027 Dementia-specific advance care planning Runs in: Switzerland · 1 site |
NA other |
UNKNOWN | 60 | University of Lausanne Hospitals OTHER |
2018-08-07 |
|
Individualized Prediction of Migraine Attacks Using a Mobile Phone App and Fitbit NCT02910921 Runs in: United States · 2 sites |
NA other |
COMPLETED | 19 | Second Opinion Health INDUSTRY |
2018-08-06 |
|
Prospective Evaluation of a Smartphone Application, GoCheckKids™, to Detect Amblyopia Risk Factors in Young Children NCT03447171 App Vision Screening Runs in: United States · 1 site |
NA other |
COMPLETED | 207 | Gobiquity Mobile Health INDUSTRY |
2018-08-03 |
|
Feru-guard for Behavioral Symptoms in Dementia NCT03451760 Feru-guard 100M; Feru-guard 100M Placebo |
PHASE2 other |
UNKNOWN | 70 | Glovia Co., Ltd. INDUSTRY |
2018-08-03 |
|
Effects of the Cognitive Enhancing ICT Contents in Patients With Mild Cognitive Impairment NCT03405857 Cognitive rehabilitation program Runs in: South Korea · 1 site |
NA other |
COMPLETED | 40 | Samsung Medical Center OTHER |
2018-08-02 |
|
Effects of an 8 Component Botanical Supplement on Mild and Moderate Alzheimer's Patients NCT03611439 ReBuilder; Placebo |
NA other |
COMPLETED | 50 | Genescient Corporation INDUSTRY |
2018-08-02 |
|
A Phase 1, Corplex™ Donepezil Transdermal System Compared to Oral Aricept® NCT02968719 Donepezil TDS Version A; Donepezil TDS Version B; Aricept; Donepezi... Runs in: United States · 1 site |
PHASE1 symptomatic-cholinergic |
COMPLETED | 107 | Corium, Inc. INDUSTRY |
2018-08-01 |
|
A Bioequivalence Study of Corplex™ Donepezil Transdermal Delivery System Compared to Aricept® NCT03259958 Donepezil TDS; Aricept Runs in: United States · 1 site |
PHASE1 symptomatic-cholinergic |
COMPLETED | 86 | Corium, Inc. INDUSTRY |
2018-08-01 |
|
Feasibility Study in Subjects With Mild to Moderate Alzheimer's Disease NCT02560753 T3D-959 Runs in: United States · 3 sites |
PHASE1|PHASE2 other |
COMPLETED | 36 | T3D Therapeutics, Inc. INDUSTRY |
2018-07-30 |
|
Study of SB-742457 or Donepezil Versus Placebo in Subjects With Mild-to-moderate Alzheimer's Disease NCT00708552 SB-742457; Donepezil; Placebo Runs in: Bulgaria; Chile; Czechia; Estonia; Germany; Greece; Mexic... · 72 sites |
PHASE2 symptomatic-cholinergic |
COMPLETED | 576 | GlaxoSmithKline INDUSTRY |
2018-07-27 |
|
Living With Frontotemporal Dementia NCT01738386 Runs in: United States · 3 sites |
NA other |
TERMINATED | 16 | National Human Genome Research Institute (NHGRI) NIH |
2018-07-26 |
|
Clinical Trial of CT1812 in Mild to Moderate Alzheimer's Disease NCT02907567 CT1812; Placebo Runs in: Australia · 4 sites |
PHASE1|PHASE2 other |
COMPLETED | 19 | Cognition Therapeutics INDUSTRY |
2018-07-26 |
|
Aging Stereotypes and Prodromal Alzheimer's Disease NCT03138018 Diagnosis of MCI versus No MCI (SCI or healthy patient); Diagnosis ... Runs in: France · 1 site |
NA other |
UNKNOWN | 260 | Assistance Publique Hopitaux De Marseille OTHER |
2018-07-26 |
|
Exploring the Use of Transdermal Methylphenidate to Reduce Fall Risk in Patients With Dementia. NCT01825577 Transdermal Methylphenidate Runs in: United States · 1 site |
PHASE4 other |
TERMINATED | 14 | St. Louis University OTHER |
2018-07-24 |
|
Effects of Visual Art Training on Dementia NCT03175822 Visual Arts Training Runs in: Canada · 1 site |
NA other |
COMPLETED | 83 | York University OTHER |
2018-07-24 |
|
Efficacy And Safety Of CX516 In Elderly Participants With Mild Cognitive Impairment. NCT00040443 CX516; Placebo Runs in: United States · 8 sites |
PHASE2 other |
COMPLETED | 175 | RespireRx INDUSTRY |
2018-07-23 |
|
Multi-centre Study of HTL0018318 in Patients as an add-on to Standard-of-care NCT03456349 HTL0018318; Placebo Runs in: Czechia; Poland; Slovakia; Spain · 4 sites |
PHASE1 other |
COMPLETED | 60 | Nxera Pharma UK Limited INDUSTRY |
2018-07-20 |
|
HIV - Monotherapy in Switzerland (MOST-ch) NCT00531986 Lopinavir-Monotherapy; HAART Runs in: Switzerland · 6 sites |
PHASE4 other |
TERMINATED | 60 | Cantonal Hospital of St. Gallen OTHER |
2018-07-18 |
|
Clinical Evaluation of Florbetapir F 18 (18F-AV-45) NCT01518374 Florbetapir F 18 Runs in: United States · 26 sites |
PHASE2 other |
COMPLETED | 1,768 | Avid Radiopharmaceuticals INDUSTRY |
2018-07-18 |
|
Accelerated Diffusion MRI for Diagnosis of Hungtington Disease NCT01884181 Runs in: Taiwan · 1 site |
NA other |
COMPLETED | 80 | Wang . Jiun-Jie OTHER |
2018-07-18 |
This table is wider than a phone screen — swipe it sideways to see the rest.
Where these trials come from
- Registry
- ClinicalTrials.gov, pulled through their public API (v2)
- Trials in the file
- 7,816
- Source file
- trials.csv (3.8 MB, 7816 rows)
- Basis
- Measured These are registry records as submitted by each study's sponsor.
What could make this misleading
Sponsors enter their own data and do not always keep it current, so "recruiting" can be out of date by months or years. Enrollment figures may be targets rather than actual numbers; the downloaded file says which for each trial. Trials that were never registered do not appear at all, and the intervention class is this project's own grouping, not the registry's.
Always check the official record before acting on anything here. This is a summary, not medical advice.
From the research library
The highest-scoring studies we hold on this subject, each summarised in plain English. Scores are alzhub's usefulness score, not a verdict on the science.
Clinical trials
- MINocyclinE to Reduce inflammation and blood-brain barrier leakage in small Vessel diseAse (MINERVA): A phase II, randomized, double-blind, placebo-controlled experimental medicine trial
- Safety and efficacy of crenezumab in cognitively unimpaired carriers of the PSEN1Glu280Ala mutation at risk for autosomal-dominant Alzheimer's disease in Colombia (API ADAD Colombia Trial): a phase 2, randomised, double-blind, placebo-controlled trial
- Study of mirtazapine for agitated behaviours in dementia (SYMBAD): a randomised, double-blind, placebo-controlled trial
- Randomized, double-blind study of zervimesine in mild to moderate Alzheimer's disease
- Efficacy assessment of an active tau immunotherapy in Alzheimer's disease patients with amyloid and tau pathology: a post hoc analysis of the "ADAMANT" randomised, placebo-controlled, double-blind, multi-centre, phase 2 clinical trial